Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

Pfizer share price gained 13% in the intraday trades on Tuesday post Q4 Results, dividend announcement and despite stock ...

3SBio will receive an upfront payment of $1.25B and is eligible to receive milestone payments associated with certain development, regulatory and commercial milestones up to $4.8B as well as tiered ...

Shares of Honda India Power and HLE Glascoat were locked in a 20 per cent upper circuit on Tuesday after their profit doubled in Q4FY25 ...

Today, companies across sectors including DLF, Pfizer, Zydus Wellness, One Mobikwik Systems, Restaurant Brands Asia, Bharat ...

Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.'s bispecific antibody ...

Shares of Pfizer Ltd are in news today rose after the firm reported a stellar set of Q4 earnings. The pharma firm reported a 85% year-on-year (YoY) rise in net profit at Rs 331 crore for the fourth ...

Pfizer stated that the drug candidate, which is being evaluated for non-small cell lung cancer, metastatic colorectal cancer ...

Pfizer also plans to make a $100 million equity investment in the Chinese biotechnolgoy company after the transaction closes, ...